224 related articles for article (PubMed ID: 12534775)
21. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
Wild CP; Hudson GJ; Sabbioni G; Chapot B; Hall AJ; Wogan GN; Whittle H; Montesano R; Groopman JD
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):229-34. PubMed ID: 1339083
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.
Kensler TW; Egner PA; Wang JB; Zhu YR; Zhang BC; Lu PX; Chen JG; Qian GS; Kuang SY; Jackson PE; Gange SJ; Jacobson LP; Muñoz A; Groopman JD
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S310-8. PubMed ID: 15508099
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
25. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
[TBL] [Abstract][Full Text] [Related]
26. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
27. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.
Chen CJ; Wang LY; Lu SN; Wu MH; You SL; Zhang YJ; Wang LW; Santella RM
Hepatology; 1996 Jul; 24(1):38-42. PubMed ID: 8707279
[TBL] [Abstract][Full Text] [Related]
28. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
29. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
Wogan GN; Kensler TW; Groopman JD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
[TBL] [Abstract][Full Text] [Related]
30. Towards global control of liver cancer?
Stuver SO
Semin Cancer Biol; 1998 Aug; 8(4):299-306. PubMed ID: 9870036
[TBL] [Abstract][Full Text] [Related]
31. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
32. A worldwide perspective on the epidemiology and primary prevention of liver cancer.
Keehn DM; Frank-Stromborg M
Cancer Nurs; 1991 Aug; 14(4):163-74. PubMed ID: 1655242
[TBL] [Abstract][Full Text] [Related]
33. A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses.
Moudgil V; Redhu D; Dhanda S; Singh J
J Environ Pathol Toxicol Oncol; 2013; 32(2):165-75. PubMed ID: 24099430
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection.
Tabor E
J Med Virol; 1989 Jan; 27(1):1-6. PubMed ID: 2537873
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of digestive tract cancers in India. III. Liver.
Dhir V; Mohandas KM
Indian J Gastroenterol; 1998; 17(3):100-3. PubMed ID: 9695391
[TBL] [Abstract][Full Text] [Related]
37. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.
Omer RE; Kuijsten A; Kadaru AM; Kok FJ; Idris MO; El Khidir IM; van 't Veer P
Nutr Cancer; 2004; 48(1):15-21. PubMed ID: 15203373
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: risk factors other than HBV.
Villa E; Melegari M; Scaglioni PP; Trande P; Cesaro P; Manenti F
Ital J Gastroenterol; 1991; 23(7):457-60. PubMed ID: 1660333
[TBL] [Abstract][Full Text] [Related]
39. Changing epidemiology of hepatocellular carcinoma in Asia.
Goh GB; Chang PE; Tan CK
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological characteristics and risk factors of hepatocellular carcinoma.
Chen CJ; Yu MW; Liaw YF
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S294-308. PubMed ID: 9407350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
